AEON Biopharma (AEON) Retained Earnings (2020 - 2026)
AEON Biopharma (AEON) posted Retained Earnings of -$470.8 million for Q4 2025, down 213.78% sequentially from $413.8 million in Q3 2025, and down 9.09% YoY from -$517.9 million in Q4 2024.
AEON Biopharma (AEON) Retained Earnings (2020 - 2026) Analysis & Trends
AEON Biopharma has reported Retained Earnings for 6 years, with the latest figure at -$470.8 million in Q4 2025.
- Quarterly Retained Earnings fell 9.09% year-over-year to -$470.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$470.8 million (down 9.09% YoY) and the FY2025 annual result came in at -$470.8 million, down 9.09% from the prior year.
- Retained Earnings retreated to -$470.8 million in Q4 2025 per AEON's latest filing, from $413.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at $413.8 million in Q3 2025 and troughed at -$473.6 million in Q4 2023.
- A 5-year average of -$48.4 million and a median of -$7.4 million in 2023 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 585362.5% in 2022, down 36301.26% in 2022.
- Over 5 years, Retained Earnings stood at $32000.0 in 2021, then soared by 585362.5% to $187.3 million in 2022, then tumbled by 352.79% to -$473.6 million in 2023, then rose by 8.87% to -$431.6 million in 2024, then retreated by 9.09% to -$470.8 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$470.8 million, $413.8 million, and $413.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 4.38 Bn |
| 10 | AEON Biopharma | 9.54 Mn | 6.11 Mn | - | -483.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -483.80 Mn |
| Dec 31, 2025 | -470.82 Mn |
| Sep 30, 2025 | 413.80 Mn |
| Jun 30, 2025 | 413.28 Mn |
| Mar 31, 2025 | 411.17 Mn |
| Dec 31, 2024 | -431.60 Mn |
| Sep 30, 2024 | -433.68 Mn |
| Jun 30, 2024 | -427.51 Mn |
| Mar 31, 2024 | 393.24 Mn |
| Dec 31, 2023 | -473.60 Mn |
| Sep 30, 2023 | -447.40 Mn |
| Jun 30, 2023 | -11.49 Mn |
| Mar 31, 2023 | -7.35 Mn |
| Dec 31, 2022 | 187.35 Mn |
| Sep 30, 2022 | -11.58 Mn |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 32,000.00 |
| Jun 30, 2021 | -22.87 Mn |